MapLight Therapeutics, Inc. (MPLT)
22.61
+1.44
(+6.80%)
USD |
NASDAQ |
Apr 06, 16:00
22.46
-0.15
(-0.66%)
After-Hours: 20:00
MapLight Therapeutics EPS Diluted (Quarterly) : -1.807 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CDT Equity, Inc. | -329.03 |
| LENZ Therapeutics, Inc. | -1.155 |
| Liminatus Pharma, Inc. | -0.3018 |
| Oruka Therapeutics, Inc. | -0.5436 |
| Maze Therapeutics, Inc. | -0.7007 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -79.55M |
| Total Expenses (Quarterly) | 79.55M |
| Enterprise Value | 660.18M |
| Earnings Yield | -15.42% |
| Normalized Earnings Yield | -15.42 |